South Dakota Investment Council’s Achillion Pharmaceuticals ACHN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-1,777,037
Closed -$10.7M 609
2019
Q4
$10.7M Sell
1,777,037
-166,060
-9% -$961K 0.22% 99
2019
Q3
$7M Buy
1,943,097
+167,970
+9% +$648K 0.14% 164
2019
Q2
$4.76M Sell
1,775,127
-74,875
-4% -$221K 0.1% 170
2019
Q1
$5.48M Hold
1,850,002
0.12% 154
2018
Q4
$2.94M Buy
1,850,002
+663,000
+56% +$1.87M 0.07% 211
2018
Q3
$4.37M Buy
1,187,002
+439,402
+59% +$1.31M 0.1% 181
2018
Q2
$2.12M Sell
747,600
-84,400
-10% -$287K 0.05% 303
2018
Q1
$3.09M Hold
832,000
0.07% 211
2017
Q4
$2.4M Sell
832,000
-11,500
-1% -$41.8K 0.05% 276
2017
Q3
$3.79M Hold
843,500
0.08% 194
2017
Q2
$3.87M Hold
843,500
0.08% 191
2017
Q1
$3.55M Hold
843,500
0.07% 194
2016
Q4
$3.48M Buy
843,500
+172,900
+26% +$919K 0.07% 203
2016
Q3
$5.43M Hold
670,600
0.11% 152
2016
Q2
$5.23M Sell
670,600
-40,900
-6% -$351K 0.11% 152
2016
Q1
$5.49M Buy
711,500
+44,100
+7% +$323K 0.12% 143
2015
Q4
$7.2M Sell
667,400
-22,900
-3% -$208K 0.16% 123
2015
Q3
$4.77M Hold
690,300
0.11% 146
2015
Q2
$6.12M Sell
690,300
-40,700
-6% -$385K 0.12% 129
2015
Q1
$7.21M Sell
731,000
-31,400
-4% -$392K 0.14% 121
2014
Q4
$9.34M Buy
762,400
+197,500
+35% +$2.41M 0.18% 102
2014
Q3
$5.64M Buy
+564,900
New +$5.24M 0.11% 133

South Dakota Investment Council's ACHN Position: Q1 2020 in Review

South Dakota Investment Council sold out of Achillion Pharmaceuticals (ACHN) in Q1 2020, closing a stake of 1,777,037 shares — an estimated $10.7M sold.

South Dakota Investment Council first reported a position in ACHN in Q3 2014 and held it in 22 quarters. The position peaked at $10.7M in Q4 2019. 0 funds tracked by Wall St. Rank hold ACHN as of Q1 2020.

  • South Dakota Investment Council reported no remaining Achillion Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • South Dakota Investment Council sold 1,777,037 Achillion Pharmaceuticals shares in Q1 2020, an estimated $10.7M.
  • South Dakota Investment Council first reported a position in Achillion Pharmaceuticals in Q3 2014 and held it in 22 quarters.
  • South Dakota Investment Council's Achillion Pharmaceuticals position peaked at $10.7M in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q1 2020.

Based on South Dakota Investment Council's 13F filing for Q1 2020, filed 11 May 2020.